What Our Analysts Know About Ambev

Large-cap Consumer Staples company Ambev has moved -0.9% so far today on a volume of 5,992,805, compared to its average of 15,623,704. In contrast, the S&P 500 index moved -0.0%.

Ambev trades -12.43% away from its average analyst target price of $3.62 per share. The 7 analysts following the stock have set target prices ranging from $2.7 to $5.0, and on average have given Ambev a rating of buy.

Anyone interested in buying ABEV should be aware of the facts below:

  • Ambev's current price is -63.5% below its Graham number of $8.68, which implies the stock has a margin of safety

  • Ambev has moved 23.6% over the last year, and the S&P 500 logged a change of 11.5%

  • Based on its trailing earnings per share of 0.2, Ambev has a trailing 12 month Price to Earnings (P/E) ratio of 15.8 while the S&P 500 average is 15.97

  • ABEV has a forward P/E ratio of 16.7 based on its forward 12 month price to earnings (EPS) of $0.19 per share

  • The company has a price to earnings growth (PEG) ratio of 2.65 — a number near or below 1 signifying that Ambev is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 0.59 compared to its sector average of 4.29

  • Ambev S.A., through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, other non-alcoholic beverages, malt, and food products.

  • Based in São Paulo, the company has 52,000 full time employees and a market cap of $50.91 Billion. Ambev currently returns an annual dividend yield of 23.8%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.